Midkine News 2020, page-15

But Maldowl. The Pacific Edge sales volume is finally ratcheting up due to COVID. @4% the Cellmid royalty would be US$30 per test.

I know this recenue may not be as much as we once imagined but it is real and it is ongoing. Once clinical practice changes it tends to stay that way.

cheers

"

Pacific Edge Limited (NZX: PEB), has been notified by Novitas¹ that the LCD: Biomarkers for Oncology (L35396) provides coverage for Cxbladder, CPT codes 0012M (Cxbladder Detect) and 0013M (Cxbladder Monitor), for tests performed on or after July 1, 2020 that are medically necessary.

This includes reimbursement for all Cxbladder tests performed for patients covered by the Centers for Medicare and Medicaid Services (CMS) across the USA, at the already determined national CMS price for Cxbladder of US$760 per test.